Top Back to top

Enhancing the role of HSCT clinical pharmacist and pharmacologist

by

By Tiene Bauters, Chair Pharmacist Committee

HSCT patients are known to have a very complex pharmacotherapy. To ensure safe and effective care and to prevent and solve drug-related problems, a collaboration between clinical pharmacists, clinical pharmacologists, and other members of the multidisciplinary team is of paramount importance.

Our Strategy

The EBMT Pharmacist’s Committee was established in 2018. Our committee welcomes clinical pharmacists and clinical pharmacologists involved in paediatric and/or adult HSCT. Our strategy is to create a network and discussion forum for pharmacists and clinical pharmacologists to share experiences and knowledge and to provide education and training on specific topics and to participate in pharmacological research, and support trials within the EBMT.

Achievements

An active communication forum has been established and will be incorporated soon within the EBMT environment.

A publication highlighting Consensus recommendations for the role and competencies of the EBMT clinical pharmacist and clinical pharmacologist involved in haematopoietic stem cell transplantation was published. This position statement paper reflects the recommendations by the members of the EBMT Pharmacist Committee: “Consensus recommendations for the role and competencies of the EBMT clinical pharmacist and clinical pharmacologist involved in hematopoietic stem cell transplantation.

Langebrake C et al., Bone Marrow Transplant. DOI: 10.1038/s41409-019-0538-9.

Pharmacist Day during the EBMT Annual Meeting

During the 5th EBMT Pharmacist’s Day (Tuesday, 24 March 2020) pharmacists and clinical pharmacologists specialised in HSCT, together with their colleagues from other medical disciplines, will present relevant up-to-date topics in four educational sessions and an oral research session, where outstanding abstracts will be presented.

Some of the highlights will include pharmacotherapy in HSCT, management of adverse events and an update on infectious diseases in HSCT. A new concept will be introduced: the round table discussions where topics as JACIE accreditation for pharmacists, the role of the pharmacist in gene therapy clinical trials and drug interactions with complementary and alternatives herbs and medicines will be discussed in an interactive way.

This full-day programme will enable pharmacists to fulfil a great part of their JACIE requirements for educational activities in cellular therapy.